- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Potential Research Study Participant Registry (clinicaltrials.gov) - Feb 16, 2019
P=N/A, N=265, Completed, Enrolling by invitation --> Completed Recruiting --> Completed | N=200 --> 265 | Trial completion date: Jan 2025 --> Sep 2018 | Trial primary completion date: Jan 2025 --> Sep 2018
- |||||||||| tacrolimus topical / Generic mfg.
Trial completion, Enrollment change, Trial completion date: Tacrolimus Ointment Interest (PROTOPIC (clinicaltrials.gov) - Jun 1, 2018 P3, N=120, Completed, N=306 --> 204 Recruiting --> Completed | N=240 --> 120 | Trial completion date: Jun 2018 --> Oct 2017
- |||||||||| timapiprant (OC000459) / Chiesi
Trial completion: Effect of OC000459 on Moderate to Severe Atopic Dermatitis (clinicaltrials.gov) - Mar 26, 2018 P2, N=142, Completed, Recruiting --> Completed | N=240 --> 120 | Trial completion date: Jun 2018 --> Oct 2017 Active, not recruiting --> Completed
- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Registry for the Atopic Dermatitis Research Network (clinicaltrials.gov) - Mar 2, 2018
P=N/A, N=3386, Completed, Active, not recruiting --> Completed Recruiting --> Completed | N=2600 --> 3386 | Trial primary completion date: Feb 2020 --> Feb 2018 | Trial completion date: Feb 2020 --> Feb 2018
- |||||||||| Reimbursement, Trial primary completion date: Evaluation of an Integrated Care Project (clinicaltrials.gov) - Jan 30, 2018
P=N/A, N=3960, Enrolling by invitation, Recruiting --> Completed | N=2600 --> 3386 | Trial primary completion date: Feb 2020 --> Feb 2018 | Trial completion date: Feb 2020 --> Feb 2018 Trial primary completion date: Dec 2017 --> Dec 2018
- |||||||||| Stelara (ustekinumab) / J&J
Trial completion, Trial primary completion date: Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis (clinicaltrials.gov) - Dec 19, 2017 P2, N=32, Completed, Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Mar 2015 | Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Mar 2015 | Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Mar 2015
- |||||||||| triamcinolone acetonide topical / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - Nov 1, 2017 P=N/A, N=0, Withdrawn, Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Mar 2015 | Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Mar 2015 | Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Mar 2015 N=40 --> 0 | Active, not recruiting --> Withdrawn | Trial primary completion date: Oct 2017 --> Oct 2014
- |||||||||| Trial termination: Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis (clinicaltrials.gov) - Apr 25, 2017
P2, N=13, Terminated, Recruiting --> Completed | Initiation date: Nov 2011 --> Feb 2012 | Trial primary completion date: Dec 2016 --> Aug 2013 Completed --> Terminated; Low enrollment
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Neurobiology of the Scalp in Seborrheic Dermatitis (clinicaltrials.gov) - Mar 27, 2017
P=N/A, N=32, Completed, N=40 --> 3 | Recruiting --> Terminated; Principal Investigator and sponsor agreed to termination. Recruiting --> Completed | N=24 --> 32 | Trial primary completion date: Aug 2015 --> May 2014
- |||||||||| triamcinolone acetonide topical / Generic mfg.
Trial primary completion date, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - Mar 13, 2017 P=N/A, N=40, Active, not recruiting, Phase classification: P2 --> P2b Trial primary completion date: Oct 2016 --> Oct 2017
- |||||||||| Reimbursement, Trial primary completion date: Evaluation of an Integrated Care Project (clinicaltrials.gov) - Mar 9, 2017
P=N/A, N=3960, Enrolling by invitation, Trial primary completion date: Oct 2016 --> Oct 2017 Trial primary completion date: Nov 2015 --> Dec 2017
- |||||||||| AIMab7195 / Nestle
Trial completion, Trial primary completion date: Safety and Tolerability of XmAb (clinicaltrials.gov) - Jan 24, 2017 P1, N=72, Completed, N=140 --> 17 | Recruiting --> Terminated | Trial primary completion date: Mar 2016 --> Aug 2016; By sponsor decision due to difficulty of recruitment Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Sep 2015
- |||||||||| Enrollment open, Enrollment change, Trial primary completion date: Bleach Bath Treatment of Adults With Atopic Dermatitis (clinicaltrials.gov) - Dec 29, 2016
P=N/A, N=30, Recruiting, Active, not recruiting --> Completed Completed --> Recruiting | N=46 --> 30 | Trial primary completion date: Apr 2016 --> May 2017
- |||||||||| tacrolimus topical / Generic mfg.
Trial primary completion date: Tacrolimus Ointment Interest (PROTOPIC (clinicaltrials.gov) - Dec 7, 2016 P3, N=240, Recruiting, Completed --> Recruiting | N=46 --> 30 | Trial primary completion date: Apr 2016 --> May 2017 Trial primary completion date: Dec 2016 --> Dec 2017
- |||||||||| Trial completion, Trial primary completion date: Randomized Controlled Trial of an Eczema Care Plan (clinicaltrials.gov) - Dec 1, 2016
P=N/A, N=211, Completed, Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Sep 2016
- |||||||||| SB011 / Sterna Biologicals
Enrollment closed, Trial primary completion date: Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema (clinicaltrials.gov) - Nov 8, 2016 P2a, N=26, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2016
- |||||||||| Trial primary completion date, IO biomarker: Interferon Responses in Eczema Herpeticum (clinicaltrials.gov) - Oct 21, 2016
P=N/A, N=84, Completed, Trial primary completion date: Jun 2016 --> Jan 2017 Trial primary completion date: Aug 2016 --> Jan 2016
- |||||||||| Trial primary completion date: Registry for the Atopic Dermatitis Research Network (clinicaltrials.gov) - Oct 19, 2016
P=N/A, N=2600, Recruiting, Trial primary completion date: Aug 2016 --> Jan 2016 Trial primary completion date: Dec 2016 --> Feb 2020
- |||||||||| Trial completion, Enrollment change, Trial primary completion date, IO biomarker: Interferon Responses in Eczema Herpeticum (clinicaltrials.gov) - Oct 19, 2016
P=N/A, N=84, Completed, Trial primary completion date: Dec 2016 --> Feb 2020 Recruiting --> Completed | N=120 --> 84 | Trial primary completion date: Dec 2016 --> Aug 2016
- |||||||||| Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date, IO biomarker: The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis (clinicaltrials.gov) - Sep 16, 2016
P=N/A, N=0, Withdrawn, Recruiting --> Completed | N=120 --> 84 | Trial primary completion date: Dec 2016 --> Aug 2016 N=240 --> 0 | Initiation date: Apr 2015 --> Sep 2013 | Terminated --> Withdrawn | Trial primary completion date: Nov 2015 --> Nov 2014
- |||||||||| Trial completion: Bleach Bath Treatment of Adults With Atopic Dermatitis (clinicaltrials.gov) - Jul 12, 2016
P=N/A, N=46, Completed, N=240 --> 0 | Initiation date: Apr 2015 --> Sep 2013 | Terminated --> Withdrawn | Trial primary completion date: Nov 2015 --> Nov 2014 Active, not recruiting --> Completed
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Vitamin D Supplementation in Polymorphic Light Eruption (clinicaltrials.gov) - Jun 14, 2016
P3, N=8, Terminated, Active, not recruiting --> Completed N=36 --> 8 | Recruiting --> Terminated | Trial primary completion date: Oct 2015 --> May 2015; Difficulties in recruiting the planned number of patients
|